DOI QR코드

DOI QR Code

Long-term results of forward intensity-modulated radiation therapy for patients with early-stage breast cancer

  • Ha, Boram (Department of Radiation Oncology, Ewha Womans University College of Medicine) ;
  • Suh, Hyun Suk (Department of Radiation Oncology, Ewha Womans University College of Medicine) ;
  • Lee, Jihae (Department of Radiation Oncology, Ewha Womans University College of Medicine) ;
  • Lee, Kyung-Ja (Department of Radiation Oncology, Ewha Womans University College of Medicine) ;
  • Lee, Rena (Department of Radiation Oncology, Ewha Womans University College of Medicine) ;
  • Moon, Byung In (Department of General Surgery, Ewha Womans University College of Medicine)
  • Received : 2013.08.13
  • Accepted : 2013.10.16
  • Published : 2013.12.31

Abstract

Purpose: To observe long-term clinical outcomes for patients with early-stage breast cancer treated with forward intensity-modulated radiation therapy (IMRT), including local control and clinical toxicities. Materials and Methods: We retrospectively analyzed a total of 214 patients with stage I-II breast cancer who were treated with breast conserving surgery followed by adjuvant breast radiation therapy between 2001 and 2008. All patients were treated using forward IMRT. The whole breast was irradiated to a dose of 50 to 50.4 Gy followed by an 8 to 12 Gy electron boost to the surgical bed. Results: The median age was 46 years (range, 21 to 82 years) and the medial follow-up time was 7.3 years (range, 2.4 to 11.7 years). Stage T1 was 139 (65%) and T2 was 75 (35%), respectively. Ipsilateral breast recurrence was observed in 3 patients. The 5- and 10-year local control rates were 99.1% and 97.8%, respectively. The cosmetic outcome was evaluated according to the Harvard scale and 89.4% of patients were scored as excellent or good. Conclusion: The whole breast radiation therapy as an adjuvant treatment using a forward IMRT technique showed excellent long-term local control as well as favorable outcomes of toxicity and cosmesis.

Keywords

References

  1. Jung KW, Park S, Won YJ, et al. Prediction of cancer incidence and mortality in Korea, 2012. Cancer Res Treat 2012;44:25-31. https://doi.org/10.4143/crt.2012.44.1.25
  2. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106. https://doi.org/10.1016/S0140-6736(05)67887-7
  3. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 2001;28:400-18. https://doi.org/10.1016/S0093-7754(01)90133-2
  4. Buchholz TA, Gurgoze E, Bice WS, Prestidge BR. Dosimetric analysis of intact breast irradiation in off-axis planes. Int J Radiat Oncol Biol Phys 1997;39:261-7.
  5. Das IJ, Cheng CW, Fein DA, Fowble B. Patterns of dose variability in radiation prescription of breast cancer. Radiother Oncol 1997;44:83-9. https://doi.org/10.1016/S0167-8140(97)00054-6
  6. Fisher J, Scott C, Stevens R, et al. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Bioi Phys 2000;48:1307-10. https://doi.org/10.1016/S0360-3016(00)00782-3
  7. Taylor ME, Perez CA, Halverson KJ, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995;31:753-64. https://doi.org/10.1016/0360-3016(94)00480-3
  8. Johansson S, Svensson H, Denekamp J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 2002;52:1207-19. https://doi.org/10.1016/S0360-3016(01)02743-2
  9. Kestin LL, Sharpe MB, Frazier RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Bioi Phys 2000;48:1559-68. https://doi.org/10.1016/S0360-3016(00)01396-1
  10. Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002;54:1336-44. https://doi.org/10.1016/S0360-3016(02)03746-X
  11. Mihai A, Rakovitch E, Sixel K, et al. Inverse vs. forward breast IMRT planning. Med Dosim 2005;30:149-54. https://doi.org/10.1016/j.meddos.2005.03.004
  12. Donovan E, Bleakley N, Denholm E, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (lMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007;82:254-64. https://doi.org/10.1016/j.radonc.2006.12.008
  13. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity- modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008;26:2085-92. https://doi.org/10.1200/JCO.2007.15.2488
  14. Freedman GM, Li T, Nicolaou N, Chen Y, Ma CC, Anderson PR. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys 2009;74:689-94. https://doi.org/10.1016/j.ijrobp.2008.08.071
  15. McDonald MW, Godette KD, Butker EK, Davis LW, Johnstone PA. Long-term outcomes of IMRT for breast cancer: a single institution cohort analysis. Int J Radiat Oncol Bioi Phys 2008;72:1031-40. https://doi.org/10.1016/j.ijrobp.2008.02.053
  16. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6. https://doi.org/10.1016/0360-3016(95)00060-C
  17. Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and ll carcinoma of the breast. Int J Radiat Oncol Biol Phys 1979;5:257-61. https://doi.org/10.1016/0360-3016(79)90729-6
  18. Barnett GC, Wilkinson JS, Moody AM, et al. Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years. Int J Radiat Oncol Bioi Phys 2012;82:715-23. https://doi.org/10.1016/j.ijrobp.2010.10.068
  19. Harsolia A, Kestin L, Grills I, et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. lntJ Radiat Oncol Biol Phys 2007;68:1375-80. https://doi.org/10.1016/j.ijrobp.2007.02.044
  20. Nielsen MH, Berg M, Pedersen AN, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol 2013;52:703- 10. https://doi.org/10.3109/0284186X.2013.765064
  21. Frazier RC, Vicini FA, Sharpe MB, et al. Impact of breathing motion on whole breast radiotherapy: a dosimetric analysis using active breathing control. Int J Radiat Oncol Biol Phys 2004;58:1041- 7. https://doi.org/10.1016/j.ijrobp.2003.07.005

Cited by

  1. The effect of laughter therapy on radiation dermatitis in patients with breast cancer: a single-blind prospective pilot study vol.7, pp.None, 2013, https://doi.org/10.2147/ott.s72973
  2. Determination of the optimal time for tamoxifen treatment in combination with radiotherapy vol.49, pp.5, 2013, https://doi.org/10.3892/ijo.2016.3687
  3. Dosimetric evaluation of incidental irradiation to the axilla during whole breast radiotherapy for patients with left-sided early breast cancer in the IMRT era vol.95, pp.26, 2013, https://doi.org/10.1097/md.0000000000004036
  4. Cardiac dose-sparing effects of deep-inspiration breath-hold in left breast irradiation : Is IMRT more beneficial than VMAT? vol.193, pp.10, 2013, https://doi.org/10.1007/s00066-017-1167-0
  5. A Hybrid Conformal Planning Technique with Solitary Dynamic Portal for Postmastectomy Radiotherapy with Regional Nodes vol.42, pp.3, 2013, https://doi.org/10.4103/jmp.jmp_3_17
  6. Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life vol.9, pp.None, 2013, https://doi.org/10.1038/s41598-019-39469-8
  7. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and op vol.14, pp.1, 2013, https://doi.org/10.1186/s13014-019-1363-4
  8. Comparison of the Oncological Efficacy Between Intraoperative Radiotherapy With Whole-Breast Irradiation for Early Breast Cancer: A Meta-Analysis vol.11, pp.None, 2013, https://doi.org/10.3389/fonc.2021.759903